Starpharma Holdings reported AUD419.92M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesoblast USD 1.29B 8.58M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025